$5.04
0.01[0.20%]
At close: Apr 24
$5.01
-0.0300[-0.60%]
After Hours: 4:00PM EDT
ImmuCell
(NASDAQ:ICCC)ImmuCell Stock (NASDAQ:ICCC), Earnings Estimates, EPS, and Revenue
ImmuCell reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 27
EPS
$-0.150
Quarterly Revenue
$5.1M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$17.5M
Analyze the earnings history of ImmuCell using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | ICCC | Q1 | -$0.30 | — | — | — | $3.45M | — | — | — | Get Alert |
| 02/27/2024 | PM | ICCC | Q4 | -$0.21 | — | -$0.15 | — | $3.91M | — | $5.10M | — | Get Alert |
| 11/13/2023 | PM | ICCC | Q3 | -$0.08 | — | -$0.12 | — | $4.80M | — | $5.40M | — | Get Alert |
| 08/10/2023 | PM | ICCC | Q2 | -$0.09 | — | -$0.18 | — | $3.86M | — | $3.53M | — | Get Alert |
| 05/11/2023 | PM | ICCC | Q1 | $0.07 | — | -$0.30 | — | $6.00M | — | $3.45M | — | Get Alert |
| 02/21/2023 | PM | ICCC | Q4 | $0.01 | — | -$0.21 | — | $5.44M | — | $3.91M | — | Get Alert |
| 11/21/2022 | PM | ICCC | Q3 | $0.02 | — | -$0.08 | — | $5.15M | $5.40M | $4.80M | -11.19% | Get Alert |
| 08/11/2022 | PM | ICCC | Q2 | $0.02 | — | -$0.09 | — | $4.54M | — | $3.86M | — | Get Alert |
| 05/12/2022 | PM | ICCC | Q1 | -$0.06 | — | $0.09 | — | $4.11M | $5.40M | $6.00M | 11.11% | Get Alert |
| 02/22/2022 | PM | ICCC | Q4 | $0.03 | — | $0.01 | — | $3.74M | $5.40M | $5.44M | 0.81% | Get Alert |
| 11/15/2021 | PM | ICCC | Q3 | -$0.04 | — | $0.02 | — | $3.72M | $5.40M | $5.15M | -4.63% | Get Alert |
| 08/12/2021 | PM | ICCC | Q2 | -$0.11 | — | $0.02 | — | $2.97M | $5.40M | $4.54M | -15.89% | Get Alert |
| 05/13/2021 | PM | ICCC | Q1 | -$0.02 | $0.05 | -$0.06 | -220.00% | $4.91M | $5.40M | $4.11M | -23.94% | Get Alert |
| 02/22/2021 | PM | ICCC | Q4 | -$0.04 | — | $0.03 | — | $3.63M | $4.00M | $3.74M | -6.42% | Get Alert |
| 11/12/2020 | PM | ICCC | Q3 | -$0.07 | -$0.08 | -$0.04 | 50.00% | $2.97M | $3.27M | $3.72M | 13.85% | Get Alert |
| 08/12/2020 | PM | ICCC | Q2 | -$0.09 | -$0.10 | -$0.11 | -10.00% | $2.71M | — | $2.97M | — | Get Alert |
| 05/13/2020 | PM | ICCC | Q1 | $0.03 | — | -$0.02 | — | $4.41M | — | $4.91M | — | Get Alert |
| 02/18/2020 | PM | ICCC | Q4 | -$0.19 | — | -$0.06 | — | $2.94M | — | $3.63M | — | Get Alert |
| 11/11/2019 | PM | ICCC | Q3 | -$0.17 | — | -$0.07 | — | $2.15M | — | $2.97M | — | Get Alert |
FAQ
When is ImmuCell (NASDAQ:ICCC) reporting earnings?
ImmuCell (ICCC) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
What were the latest earnings per share (EPS) for ImmuCell (NASDAQ:ICCC)?
The Actual EPS was $-0.15, which missed the estimate of $0.00.
What were ImmuCell’s (NASDAQ:ICCC) revenues?
The Actual Revenue was $5.1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.